Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

BNTC US Equity

Benitec Biopharma Inc.Health Care · Pharmaceutical Preparations · CIK 1808898 · FY ends Jun 30
$13.38
+0.50 (+3.88%)
USD · as of 2026-08-19 · marketstack

Documents

6 of 6 10-Ks readable here
Period endFiledFormRead hereEDGAR
2025-06-302025-09-2210-Kread · risk factors · MD&Aindex · original · 0001193125-25-211361
2024-06-302024-09-2610-Kread · risk factors · MD&Aindex · original · 0001193125-24-226968
2023-06-302023-09-2110-Kread · risk factors · MD&Aindex · original · 0001193125-23-239121
2022-06-302022-09-0210-Kread · risk factors · MD&Aindex · original · 0001193125-22-237075
2021-06-302021-09-2010-Kread · risk factors · MD&Aindex · original · 0001193125-21-276758
2020-06-302020-09-2310-Kread · risk factors · MD&Aindex · original · 0001193125-20-252381

Risk registerwhich risk-factor headings appeared in which year

260 captions · 6 filings

Descriptive and within-name: this is what changed in the wording of one firm's own filings.

260 captions across 6 filings25 added200 dropped33 in every year6 of 6 10-Ks on file are cached here
Risk-factor caption202020212022202320242025Years
·····1
····2
···3
··4
··4
··4
·5
·5
·5
·5
·5
·5
·5
·5
·5
·5
·5
·5
·5
·5
·5
·5
·5
·5
·5
·····1
·····1
·····1
·····1
·····1
····2 rw
·····1
·····1
····2
·····1
·····1
····2
····2
·····1
····2
·····1
·····1
·····1
····2
·····1
·····1
····2 rw
····2
·····1
····2
·····1
·····1
·····1
·····1
·····1
·····1
·····1
····2
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·5 rw
·····1
·····1
·····1
·····1
····2 rw
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
····2
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
····2 rw
·····1
····2 rw
·····1
·····1
···3 rw
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
····2
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·5
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
····2 rw
····2 rw
6
6 rw
6 rw
6
6
6 rw
6 rw
6 rw
6 rw
6 rw
6
6
6 rw
6 rw
6 rw
6 rw
6 rw
6
6
6
6 rw
6 rw
6
6
6 rw
6 rw
6 rw
6
6
6 rw
6
6 rw
6 rw
The filer's own 10-K text · 6 filings read

Rows are the filing's own headings, verbatim — nothing is summarized or generated.

A blank cell means the filer did not print that heading that year — not that the risk ended.

Gates: 5+ captions · 50% of Item 1A · match at Jaccard 0.6.

Filing languagedocument length, negation and hedging — chart it against price on GRAPH

6 filings measured

Descriptive and within-name: this is what changed in the wording of one firm's own filings.

FiledPeriod endDocument wordsItem 1A wordsNegation / 10kHedging / 10kFiling
2020-09-232020-06-3064,34127,37975.69184.49read · EDGAR ↗
2021-09-202021-06-3061,57726,10274.7191.47read · EDGAR ↗
2022-09-022022-06-3060,31226,41176.27193read · EDGAR ↗
2023-09-212023-06-3060,93626,22375190.53read · EDGAR ↗
2024-09-262024-06-3058,52326,15477.92194.62read · EDGAR ↗
2025-09-222025-06-3057,72124,92875.71187.63read · EDGAR ↗

plot against the price on GRAPH: Document length · Item 1A length · Negation per 10k words · Hedging per 10k words

The filer's own 10-K text · 6 filings measured

House wordlists, not a licensed dictionary and not tuned against returns.

9 negation words · 40 hedging words — hover to read both lists.

Each point sits at its filing date and is held flat until the next filing.